Vaccines that Selectively Induce Type I T-cell Responses to Tumor Associated Antigens

Time: 2:15 pm
day: Day Two

Details:

  • Discovery of new molecular targets for cancer immunotherapies
  • Clinical trial data testing HER-2–based cancer vaccines

Speakers: